Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children

NCT01388842 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
92
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Epicentre

Collaborators